LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51

Xinyu Zhang(Shanghai Jiao Tong University), Jie Hong(Shanghai Jiao Tong University), Hua Xiong(Shanghai Jiao Tong University), Yingying Cao(Nanjing Agricultural University), Debing Shi(Shanghai Medical College of Fudan University), Fangfang Guo(Southern Medical University), Haoyan Chen(Shanghai Jiao Tong University), Minhao Yu(Shanghai Jiao Tong University), Yanru Ma(Shanghai Jiao Tong University), Xiaoqiang Zhu(Shanghai Institute of Hematology), Chaoqin Shen(Sun Yat-sen University), Yuqing Yan(Shanghai Jiao Tong University), Jie He(Third People's Hospital of Hangzhou), Ziyun Gao(Nanchang University), Dan Ma(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Tianying Tong(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University)
Oncogene
March 11, 2023
10.1038/s41388-023-02657-y
Cited by 43

Related Papers

Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
m6A-dependent glycolysis enhances colorectal cancer progression
|Molecular Cancer|2020|465
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434
<i>F. nucleatum</i> targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer
|Gut|2020|303
Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p
|Gastroenterology|2021|291